To our knowledge, this study is the first to investigate the actual immunomodulatory effect of the MUC2 molecules secreted by ovarian cancer cells based on a molecular pathology approach, which provided new insight into the relationship between cancer cells and TAMs. Here, MUC2 is linked to ovarian cancer.